County
Tippecanoe Emergency Ambulance Service
The current listed document is more than 24 months old and may be outdated.
Drugs and doses36
A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Cefazolin7
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 12 mg | IV | not captured | standing | pages 20, 71, 72 |
| Other | adult | 12 mg | IV | not captured | standing | pages 20, 71 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 5 mg | NEB | not captured | standing | pages 25, 26, 71, 74 |
| Allergic reaction | peds | 5 mg | NEB | not captured | standing | pages 25, 26, 71, 74 |
| Asthma / bronchospasm | adult | 5 mg | NEB | not captured | standing | page 71 |
| CHF / pulmonary edema | adult | 5 mg | NEB | not captured | standing | pages 27, 71, 74 |
| CHF / pulmonary edema | peds | 5 mg | NEB | not captured | standing | pages 27, 71, 74 |
| Hyperkalemia | adult | 5 mg | NEB | not captured | standing | pages 26, 33, 71, 74 |
| Hyperkalemia | peds | 5 mg | NEB | not captured | standing | pages 26, 33, 71, 74 |
| Other | adult | 5 mg | NEB | not captured | standing | pages 26, 71, 74 |
| Other | adult | 5 mg | NEB | not captured | standing | page 26 |
| Other | adult | 5 mg | NEB | not captured | standing | page 27 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 26 |
| Other | peds | 5 mg | NEB | not captured | standing | pages 26, 71, 74 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | page 21 |
| Other | adult | 150 mg | IV | not captured | standing | page 20 |
| Other | peds | 5 mg/kg | IV | not captured | standing | pages 68, 74 |
| Wide-complex tachycardia | adult | 150 mg | IV | not captured | standing | pages 20, 68, 71, 74 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV | not captured | standing | pages 20, 68, 71, 74 |
| VF / pulseless VT | adult | 300 mg | IV | not captured | standing | pages 21, 71, 74 |
| VF / pulseless VT | peds | 5 mg/kg | IV | not captured | standing | pages 21, 71, 74 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 17, 71 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 19, 67, 71, 74 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 19, 67, 71, 74 |
| Organophosphate poisoning | adult | 2 mg | IV/IM | not captured | standing | page 71 |
| Other | adult | 1 mg | IV/IO | not captured | standing | page 28 |
| Other | peds | 0.02 mg/kg (max 0.5 mg) | IV | not captured | standing | pages 67, 74 |
| Other | peds | 0.02 mg/kg (max 0.5 mg) | IV/IO | not captured | standing | page 28 |
| RSI induction | adult | 1 mg | IV/IO | not captured | standing | page 28 |
| RSI induction | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 28 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | pages 34, 71 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 33, 71 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 71 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV | not captured | standing | pages 49, 74 |
| Other | adult | 1 g | IV | not captured | standing | page 71 |
| Other | adult | 2 g | IV | not captured | standing | pages 49, 71, 74 |
| Other | adult | 2 g | IV | not captured | standing | pages 49, 74 |
| Other | adult | 2 g | IV | not captured | standing | page 71 |
| Other | peds | 1 g | IV | not captured | standing | pages 49, 71, 74 |
| Other | peds | 2 g | IV | not captured | standing | pages 49, 74 |
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Epinephrine, Etomidate, Fentanyl, Furosemide8
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV | not captured | standing | pages 32, 36, 71, 74 |
| Hypoglycemia | peds | 5 mL/kg (max 250 mL) | IV | not captured | standing | pages 32, 36, 71, 74 |
| Other | adult | 5 mL/kg (max 250 mL) | IV | not captured | standing | page 36 |
| Other | peds | 5 mL/kg (max 250 mL) | IV | not captured | standing | page 36 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | PR | not captured | standing | page 36 |
| Other | peds | 2.5 mg | PR | not captured | standing | page 36 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | IV | not captured | standing | pages 20, 72 |
| Other | adult | 5 mg | IV | not captured | standing | page 72 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV | not captured | standing | pages 25, 71, 74 |
| Allergic reaction | adult | 50 mg | IM | not captured | standing | pages 25, 71, 74 |
| Allergic reaction | peds | 1 mg/kg | IV | not captured | standing | pages 25, 71, 74 |
| Allergic reaction | peds | 1 mg/kg | IM | not captured | standing | pages 25, 71, 74 |
| Other | adult | 50 mg | IV/IM | not captured | standing | pages 25, 71 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | pages 25, 71, 74 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.01 mg/kg | IM | not captured | standing | pages 25, 72, 74 |
| Allergic reaction | peds | 0.01 mg/kg | IM | not captured | standing | pages 25, 72, 74 |
| Asystole / PEA | adult | 1 mg | IV | not captured | standing | pages 22, 68, 72 |
| Asystole / PEA | adult | 1 mg | IV | not captured | standing | pages 23, 67, 72 |
| Asystole / PEA | peds | 0.1 mL/kg | IV | not captured | standing | pages 22, 68, 72 |
| Asystole / PEA | peds | 0.1 mL/kg | IV | not captured | standing | pages 23, 67, 72 |
| Bradycardia | peds | 0.1 mL/kg | IV/IO | not captured | standing | pages 19, 67, 72 |
| Cardiogenic shock | adult | 1–2 mL | IV/IO | not captured | standing | page 18 |
| Cardiogenic shock | adult | 10–20 mcg | IV/IO | not captured | standing | pages 18, 72 |
| CHF / pulmonary edema | adult | 10–20 mcg | IV/IO | not captured | standing | pages 27, 72 |
| Other | adult | 0.3 mg | IM/SQ | not captured | standing | page 26 |
| Other | adult | 0.3 mg | IM/SQ | not captured | standing | page 26 |
| Other | peds | 0.01 mg/kg (max 0.5 mg) | SQ | not captured | standing | pages 72, 74 |
| Other | peds | 0.1 mL/kg | IV/IO/ET | not captured | standing | page 74 |
| Other | peds | 1 unit | NEB | not captured | standing | pages 26, 73, 75 |
| RSI induction | adult | 10–20 mcg | IV/IO | not captured | standing | pages 28, 72 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 28 |
| RSI induction | adult | 0.3–0.4 mg/kg | IV/IO | not captured | standing | pages 28, 72, 74 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 28, 72, 74 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mcg/kg | IV/IN | not captured | standing | pages 72, 74 |
| Other | adult | 1 mcg/kg | IV | not captured | standing | page 17 |
| Other | peds | 1 mcg/kg | IV/IN | not captured | standing | pages 72, 74 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IN | not captured | standing | pages 17, 59, 72, 74 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IN | not captured | standing | page 59 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IN | not captured | standing | pages 17, 59, 72, 74 |
| RSI induction | adult | 1 mcg/kg | IV/IO | not captured | standing | page 28 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40–80 mg | IV | not captured | standing | pages 27, 72 |
| Other | adult | 40 mg | IV | not captured | standing | page 72 |
G–L Glucagon, Hydroxocobalamin, Ipratropium, Ketamine, Ketorolac, Lidocaine, Lorazepam7
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 32, 36, 72, 74 |
| Hypoglycemia | peds | 1 mg | IM/IN | not captured | standing | pages 32, 36, 72, 74 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 48 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 48 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.5 mg | NEB | not captured | standing | pages 25, 26, 71, 74 |
| Allergic reaction | peds | 0.25 mg | NEB | not captured | standing | pages 25, 26, 71, 74 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 74 |
| CHF / pulmonary edema | adult | 0.5 mg | NEB | not captured | standing | pages 27, 71, 74 |
| Other | adult | 0.5 mg | NEB | not captured | standing | pages 26, 71, 74 |
| Other | adult | 0.5 mg | NEB | not captured | standing | page 27 |
| Other | peds | 0.25 mg | NEB | not captured | standing | pages 26, 71, 74 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 4 mg/kg (max 400 mg) | IV/IM | not captured | standing | pages 72, 75 |
| Agitation | peds | 4 mg/kg | IV/IM | not captured | standing | pages 72, 75 |
| Bradycardia | adult | 1 mg/kg | IV | not captured | standing | page 19 |
| Other | adult | 1 mg/kg | IV | not captured | standing | page 20 |
| Other | adult | 1–2 mg/kg (max 200 mg) | IV/IO/IM | not captured | standing | page 28 |
| Other | adult | 2 mg/kg | IV/IM | not captured | standing | pages 36, 75 |
| Other | adult | 2 mg/kg | IV/IM | not captured | standing | page 36 |
| Other | adult | 2 mg/kg (max 200 mg) | IV | not captured | standing | page 60 |
| Other | adult | 2 mg/kg | IV | not captured | standing | pages 72, 75 |
| Other | peds | 2 mg/kg | IV/IM | not captured | standing | pages 36, 75 |
| Other | peds | 2 mg/kg | IV/IM | not captured | standing | page 36 |
| Other | peds | 2 mg/kg | IV | not captured | standing | pages 72, 75 |
| Mild to moderate pain | adult | 15–25 mg | IV/IO | not captured | standing | pages 59, 72, 75 |
| Mild to moderate pain | peds | 0.25 mg/kg | IV/IO | not captured | standing | pages 59, 72, 75 |
| Mild to moderate pain | peds | 0.25 mg/kg | IV/IO | not captured | standing | page 59 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 28, 73, 75 |
| RSI induction | peds | 1–2 mg/kg | IV/IO | not captured | standing | pages 28, 73, 75 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 mg | IV | not captured | standing | page 59 |
| Other | adult | 15 mg | IV | not captured | standing | pages 73, 75 |
| Other | adult | 30 mg | IV/IM | not captured | standing | page 59 |
| Other | adult | 30 mg | IV/IM | not captured | standing | pages 73, 75 |
| Other | adult | 60 mg | IM | not captured | standing | page 59 |
| Other | adult | 60 mg | IM | not captured | standing | pages 73, 75 |
| Other | peds | 15 mg | IV | not captured | standing | pages 73, 75 |
| Other | peds | 30 mg | IV/IM | not captured | standing | pages 73, 75 |
| Other | peds | 60 mg | IM | not captured | standing | pages 73, 75 |
| Mild to moderate pain | adult | 15 mg | IV/IM | not captured | standing | pages 59, 73, 75 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 72, 75 |
| Other | peds | 0.05 mL/kg | IO | not captured | standing | page 16 |
| Other | peds | 1–2.5 mL/kg | not captured | not captured | standing | page 69 |
| Other | peds | 1.5 mg/kg | IV/IO | not captured | standing | pages 72, 75 |
| Wide-complex tachycardia | adult | 1.5 mg/kg | IV | not captured | standing | pages 20, 72 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV | not captured | standing | pages 21, 71 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 mg | IV/IO/IM | not captured | standing | pages 36, 71, 74 |
| Other | adult | 2 mg | IV/IM/IN | not captured | standing | pages 60, 75 |
| Other | adult | 2 mg | IV/IO/IM | not captured | standing | page 36 |
| Other | adult | 2 mg | IV/IN | not captured | standing | page 71 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 36, 71, 74 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 36 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Naloxone, Nitroglycerin, Ondansetron, Oxymetazoline7
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 50 mg/kg (max 2 g) | IV | not captured | standing | page 26 |
| Asthma / bronchospasm | peds | 50 mg/kg (max 2 g) | IV | not captured | standing | page 26 |
| Other | adult | 1–2 g | IV | not captured | standing | page 72 |
| Other | adult | 2 g | IV | not captured | standing | pages 20, 21, 72 |
| Other | adult | 2 g | IV | not captured | standing | pages 20, 21, 72 |
| Other | adult | 4 g | IV | not captured | standing | pages 36, 72 |
| Other | adult | 4 g | IV | not captured | standing | pages 36, 72 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1–2 mg/kg | IV | not captured | standing | pages 25, 73, 75 |
| Allergic reaction | peds | 1–2 mg/kg | IV | not captured | standing | pages 25, 73, 75 |
| Other | adult | 1–2 mg/kg | IV | not captured | standing | pages 26, 73, 75 |
| Other | peds | 1–2 mg/kg | IV | not captured | standing | pages 26, 73, 75 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–5 mg | IV/IO/IM | not captured | standing | page 36 |
| Other | adult | 2–5 mg | IV/IN | not captured | standing | pages 73, 75 |
| Other | adult | 3–5 mg | IV | not captured | standing | page 20 |
| Other | adult | 3–5 mg | IV/IM/IN | not captured | standing | pages 60, 73 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 36 |
| Other | peds | 0.1 mg/kg | IV/IN | not captured | standing | pages 73, 75 |
| Procedural sedation | adult | 3–5 mg | IV/IO/IM/IN | not captured | standing | page 19 |
| RSI induction | adult | 3–5 mg | IV/IO/IM | not captured | standing | pages 28, 73 |
| RSI induction | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 28, 73 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 2 mg | IV | not captured | standing | pages 32, 36, 72, 75 |
| Opioid overdose | adult | 2 mg | IM/SQ | not captured | standing | pages 32, 36, 72, 75 |
| Opioid overdose | peds | 0.1 mg/kg | IV | not captured | standing | pages 32, 36, 72, 75 |
| Opioid overdose | peds | 0.1 mg/kg | IM/SQ | not captured | standing | pages 32, 36, 72, 75 |
| Other | adult | 0.4 mg | IV | not captured | standing | page 36 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 32 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 36 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 17, 73 |
| CHF / pulmonary edema | adult | 0.4–0.8 mg | SL | not captured | standing | pages 27, 73 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mg | IV | not captured | standing | pages 39, 73, 75 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 39, 73, 75 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | pages 43, 71 |
| Other | adult | 2 spray | IN | not captured | standing | page 71 |
P–R Racemic Epinephrine, Rocuronium2
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 1 unit | NEB | not captured | standing | pages 26, 73, 75 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV | not captured | standing | pages 28, 73, 75 |
| RSI induction | adult | 1 mg/kg | IV | not captured | standing | page 28 |
| RSI induction | peds | 1 mg/kg | IV | not captured | standing | pages 28, 73, 75 |
S–Z Sodium Bicarbonate, Sodium Nitrite, Sodium Thiosulfate, Thiamine, Tranexamic Acid5
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 100 mEq | IV/IO | not captured | standing | pages 33, 73, 75 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 33, 73, 75 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 34, 73, 75 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 34, 73, 75 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 34, 73, 75 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 34, 73, 75 |
Sodium Nitrite
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 300 mg | IV/IO | not captured | standing | pages 48, 73, 75 |
| Cyanide poisoning | peds | 0.2 mL/kg | IV/IO | not captured | standing | pages 48, 73, 75 |
| Other | adult | 10 mL | IV/IO | not captured | standing | page 73 |
| Other | adult | 10 mL | IV/IO | not captured | standing | page 48 |
| Other | peds | 0.2 mL/kg | IV/IO | not captured | standing | page 73 |
Sodium Thiosulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 mL | IV/IO | not captured | standing | page 48 |
| Other | adult | 50 mL | IV/IO | not captured | standing | pages 48, 73, 75 |
| Other | peds | 1 mL/kg | IV/IO | not captured | standing | pages 48, 73, 75 |
| Other | peds | 1 mL/kg | IV/IO | not captured | standing | page 48 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 200 mg | IV | not captured | standing | pages 32, 73 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV | not captured | standing | page 73 |
| Other | adult | 1 g | NEB | not captured | standing | page 44 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | pages 49, 65, 73, 75 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | pages 49, 65, 73, 75 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 75 |
Cite this
Tippecanoe Emergency Ambulance Service, United States EMS Protocol Census. 190 dose entries, effective 2024-01-01.
https://protoquiz.com/census/agencies/tippecanoe-emergency-ambulance-service/
The census is free and not for sale. Only public agencies are named.